Overview

Short-course Antimicrobial Therapy for Paediatric Respiratory Infections

Status:
Completed
Trial end date:
2020-04-01
Target enrollment:
Participant gender:
Summary
Randomized controlled double-blind non-inferiority clinical trial to determine whether five days of high-dose amoxicillin leads to comparable rates of early clinical cure compared with 10 days of high-dose amoxicillin for previously healthy children with mild community-acquired pneumonia.
Phase:
Phase 4
Details
Lead Sponsor:
Hamilton Health Sciences Corporation
Collaborator:
Children's Hospital of Eastern Ontario
Treatments:
Amoxicillin
Anti-Infective Agents